Liv Longevity Labs

AI Longevity Advisor, with integrated test & treatments marketplace.

At A Glance

<aside> ⚠️ Problem - Europeans are living longer, but not healthier.

The number of seniors living with multiple chronic diseases is projected to increase to 67% over the next 10 years. Today’s working age adults struggle to assess their current risk for developing chronic disease, to develop and stick to a plan that will reduce their risk and are priced out of proactive healthcare by private clinics charging up to €50K per year.

</aside>

<aside> 💡 Solution – AI Longevity Advisor, with integrated test & treatments marketplace.

With Liv, customers measure their chronic disease risk, receive personalized intervention protocols, and book vetted practitioners—all in one platform. It starts with an at-home, third-party epigenetic test and continues with an advisor that guides the user through understanding their results and improving them with seamless access to a curated marketplace of follow-up tests and treatments.

</aside>

<aside> 📈 Business Model - Subscription + Commission

Liv generates revenue through annual testing subscriptions (€499/year) and marketplace commissions (15% take rate).

</aside>